(Q36302677)

13 August 2017

1 reference

title

Atypical antipsychotics in psychiatric practice: practical implications for clinical monitoring (English)

1 reference

13 August 2017

5

Roger S McIntyre

1 reference

13 August 2017

Marie-Josée Poulin

1

1 reference

13 August 2017

Leonardo Cortese

series ordinal

2

1 reference

13 August 2017

Richard Williams

series ordinal

3

1 reference

13 August 2017

Nina Wine

series ordinal

4

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 August 2005

1 reference

Canadian Journal of Psychiatry

13 August 2017

published in

1 reference

13 August 2017

volume

50

1 reference

13 August 2017

issue

9

1 reference

13 August 2017

page(s)

555-562

1 reference

Consensus development conference on antipsychotic drugs and obesity and diabetes

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000909

Causes of the excess mortality of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000909

Mortality and causes of death in a total national sample of patients with affective disorders admitted for the first time between 1973 and 1993

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000909

Mortality in psychiatric patients 5 to 21 years after hospital admission in Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000909

Use of general medical services by VA patients with psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000909

Clozapine-associated diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000909

Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000909

Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000909

Long-term changes in insulin action and insulin secretion associated with gain, loss, regain and maintenance of body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000909

Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000909

Diabetes mellitus in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000909

Prevalence and correlates of diabetes in national schizophrenia samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000909

Drug-induced hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000909

Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000909

Bipolar disorder and diabetes mellitus: epidemiology, etiology, and treatment implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000909

Hyperglycemia and hypertriglyceridemia in real world patients on antipsychotic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000909

Evaluation of insulin sensitivity in healthy volunteers treated with olanzapine, risperidone, or placebo: a prospective, randomized study using the two-step hyperinsulinemic, euglycemic clamp

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000909

Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000909

Estimating the costs and benefits of new drug therapies: atypical antipsychotic drugs for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000909

Weight loss with psychiatric residents in a behavioral self control program

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000909

A study of weight reducing diets in psychiatric in-patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000909

Reinforcement and weight loss in schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000909

Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000909

Weight gain associated with neuroleptic medication: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000909

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000909

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000909

Weight change and duration of overweight and obesity in the incidence of type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000909

Olanzapine-associated diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000909

Obesity: what mental health professionals need to know

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000909

Body weight changes associated with psychopharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000909

Antipsychotic-induced weight gain and therapeutic response: a differential association.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000909

Antipsychotic drugs and obesity: is prolactin involved?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000909

Awareness of Obesity and Weight Issues Among Chronically Mentally 111 Inpatients: A Pilot Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000909

Prevalence of obesity and weight change during treatment in patients with bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000909

10.1177/070674370505000909

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference